BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10560497)

  • 1. Evidence for apoptosis in non-small cell lung carcinoma. Relationship with cell kinetics and prognosis.
    Matturri L; Colombo B; Lavezzi AM
    Anal Quant Cytol Histol; 1999 Jun; 21(3):240-4. PubMed ID: 10560497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of apoptotic index in completely resected non-small-cell lung cancer.
    Tanaka F; Kawano Y; Li M; Takata T; Miyahara R; Yanagihara K; Ohtake Y; Fukuse T; Wada H
    J Clin Oncol; 1999 Sep; 17(9):2728-36. PubMed ID: 10561347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
    Dworakowska D; Jassem E; Jassem J; Karmoliński A; Lapiński M; Tomaszewski D; Rzyman W; Jaśkiewicz K; Sworczak K; Grossman AB
    Lung Cancer; 2009 Oct; 66(1):127-33. PubMed ID: 19200616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
    Morita K; Hayashi Y; Nagao S; Watanabe Y
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of apoptosis are associated with improved survival in non-small cell lung cancer.
    Macluskey M; Baillie R; Chandrachud LM; Pendleton N; Schor AM
    Anticancer Res; 2000; 20(3B):2123-8. PubMed ID: 10928164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.
    Komaki R; Milas L; Ro JY; Fujii T; Perkins P; Allen P; Sikes CR; Mountain CF; Ordonez NG
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):787-96. PubMed ID: 9531362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M; Koomägi R
    Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on spontaneous apoptosis of human non-small cell lung cancer tissues].
    Wang Y; Li L; Tong T; Zhang X; Cheng S
    Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):92-4. PubMed ID: 11866897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of apoptosis and proliferation related genes in carcinogenesis of lung squamous cell carcinoma in rats].
    Wang J; Chen HL; Zhu RQ; Diao LM; Jang M; Yang F; Liu MQ
    Ai Zheng; 2003 May; 22(5):471-6. PubMed ID: 12753705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
    Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
    Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in apoptosis-related genes and survival of patients with early-stage non-small-cell lung cancer.
    Lee EB; Jeon HS; Yoo SS; Choi YY; Kang HG; Cho S; Cha SI; Choi JE; Park TI; Lee BH; Park RW; Kim IS; Kang YM; Kim CH; Jheon S; Jung TH; Park JY
    Ann Surg Oncol; 2010 Oct; 17(10):2608-18. PubMed ID: 20422457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
    Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
    Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
    J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
    Korkolopoulou P; Oates J; Crocker J; Edwards C
    J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer.
    Jin G; Bae EY; Yang E; Lee EB; Lee WK; Choi JE; Jeon HS; Yoo SS; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
    J Thorac Oncol; 2012 May; 7(5):808-14. PubMed ID: 22722785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer.
    Wu D; Xiong L; Wu S; Jiang M; Lian G; Wang M
    Lung Cancer; 2012 Apr; 76(1):106-11. PubMed ID: 21983100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.